MedTrace Logo

Clinical Performance Evaluation of T-TAS®01 HD Chip

NCT06087198 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2025-07-28

No results posted yet for this study

Summary

The study is being conducted to validate the clinical performance of the T-TAS 01 HD assay for measurement of thrombogenicity in patients with thrombocytopenia receiving a platelet transfusion.

Conditions

Interventions

DIAGNOSTIC_TEST

T-TAS 01 HD Assay

Disposable flow chamber microchip containing thrombogenic path to facilitate thrombus formation and occlusion

Sponsors & Collaborators

  • Fujimori Kogyo Co., Ltd.

    collaborator UNKNOWN

  • Hikari Dx, Inc.

    lead OTHER

Principal Investigators

  • Jeffrey Dahlen, Ph.D. · Hikari Dx, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-25
Primary Completion
2025-06-30
Completion
2025-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06087198 on ClinicalTrials.gov